About CartiHeal
CartiHeal is a company based in Kfar Saba (Israel) founded in 2009 was acquired by Smith & Nephew in November 2023.. CartiHeal has raised $65.8 million across 6 funding rounds from investors including Bioventus, Smith & Nephew and Elron Ventures. CartiHeal operates in a competitive market with competitors including MiMedx Group, Ossio, EpiBone, Biocomposites and Theradaptive, among others.
- Headquarter Kfar Saba, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.8 M (USD)
in 6 rounds
-
Latest Funding Round
$15 M (USD), Series D
Jul 16, 2020
-
Investors
Bioventus
& 7 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of CartiHeal
CartiHeal has successfully raised a total of $65.8M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $15 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $15.0M
-
First Round
First Round
(01 Feb 2012)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series D - CartiHeal | Valuation | Bioventus |
|
| Jan, 2018 | Amount | Series C - CartiHeal | Valuation | aMoon , Johnson & Johnson Innovation – JJDC | |
| May, 2017 | Amount | Series C - CartiHeal | Valuation | aMoon |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CartiHeal
CartiHeal has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Bioventus, Smith & Nephew and Elron Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in healthcare are focused on by aMoon.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Peregrine is focused on healthcare innovation through strategic global investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CartiHeal
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CartiHeal
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cartiheal Comparisons
Competitors of CartiHeal
CartiHeal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, EpiBone, Biocomposites and Theradaptive, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cartiheal
Frequently Asked Questions about CartiHeal
When was CartiHeal founded?
CartiHeal was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is CartiHeal located?
CartiHeal is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
Is CartiHeal a funded company?
CartiHeal is a funded company, having raised a total of $65.8M across 6 funding rounds to date. The company's 1st funding round was a Series C of $18.3M, raised on Feb 01, 2012.
What does CartiHeal do?
CartiHeal was founded in 2009 in Kfar Saba, Israel, within the medical device sector focused on orthopedics. A cell-free implant named Agili-C has been developed by the company to support bone and cartilage regeneration through a single-step procedure. This implant is CE marked for addressing focal articular cartilage and osteochondral defects in clinical settings. Operations center on advancing regenerative technologies for joint repair.
Who are the top competitors of CartiHeal?
CartiHeal's top competitors include EpiBone, Theradaptive and MiMedx Group.
Who are CartiHeal's investors?
CartiHeal has 8 investors. Key investors include Bioventus, Smith & Nephew, Elron Ventures, aMoon, and Johnson & Johnson Innovation – JJDC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.